Health Care

Preventing Heart Disease: Lisa Tate, CEO of WomenHeart February 14, 2012 Lisa Tate, CEO of WomenHeart, the National Coalition for Women with Heart Disease, discusses...	Drugs Need Friends Too January 19, 2012 Drugs approved with companion diagnostic tests represent the next wave of personalized...
BIO Asia International Conference Highlights Promise of Biotech in Asia January 12, 2012 BIO Asia will be held January 31 – February 1, 2012 in Osaka, Japan.	HIV/AIDS and Biotechnology January 6, 2012 Learn about the role biotechnology plays in the on-going fight against HIV/AIDS.

Key Documents

What Legal Issues are Presented by Biosimilars?

Follow-On Biologics Presentation

The Future of Healthcare: Personalized Medicine

Letters, Testimony & Comments

Alzheimer’s Disease: BIO's Comments on the Draft Framework for the National Plan to Address Alzheimer’s Disease

February 8 2012

Re: Draft Framework for the National Plan to Address Alzheimer's Disease Dear Ms. Glied: ...

PDUFA V: Testimony to House Committee on Energy and Commerce, Subcommittee on Health

February 1 2012

Chairmen Upton and Pitts, and Ranking Members Waxman and Pallone, it is my privilege to provide testimony before this...

Essential Health Benefit: BIO's Comments on the HHS Pre-rule Bulletin

January 31 2012

The Biotechnology Industry Organization (BIO) is pleased to submit the following comments on the Department of Health and Human Services...

Coverage with Evidence Development: BIO's Comments on the Centers for Medicare and Medicaid Services’ (CMS) public solicitation for comments on Coverage with Evidence Development (CED)

January 20 2012

Re: CED Public Solicitation Dear Dr. Jacques: ...

Orphan Drugs: BIO Submits Comments on Orphan Drug Regulations

January 17 2012

Dear Sir/Madam: The Biotechnology Industry Organization (BIO) thanks the Food and Drug Administration (FDA or Agency) for the...

More Letters, Testimony & Comments →

Press Releases

TREAT Act Offers Renewed Hope for Patients

February 15 2012

Washington, DC (February 15, 2012) – Today, the Biotechnology Industry Organization (BIO) praised Sen. Kay...

Administration‘s 2013 Budget Could Discourage Development of Cures and Breakthrough Medicines, Limit Patient Choice And Forestall Job Growth

February 14 2012

(February 14, 2011) –Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued...

Release of FDA Guidance for Biosimilars Pathway Marks Important Step Forward, Says BIO

February 9 2012

Patient Safety Must Remain Top Priority Washington, D.C. (February 9, 2012) — Biotechnology Industry...

9th Annual BIO Asia International Conference to Feature New Deal Models and Discuss the Future of Innovation in Asia

January 12 2012

WASHINGTON, D.C. (January 12, 2012) - The BIO Asia International Conference will feature industry leaders...

BIO Strongly Supports Reauthorization of PAHPA and BioShield Special Reserve Fund

November 15 2011

Reauthorization demonstrates government commitment to national security priority Washington, D.C. (November 15,...

More Press Releases →